182 related articles for article (PubMed ID: 35127901)
1. Evaluating tumor-infiltrating lymphocytes in hepatocellular carcinoma using hematoxylin and eosin-stained tumor sections.
Du M; Cai YM; Yin YL; Xiao L; Ji Y
World J Clin Cases; 2022 Jan; 10(3):856-869. PubMed ID: 35127901
[TBL] [Abstract][Full Text] [Related]
2. A new method for evaluating tumor-infiltrating lymphocytes (TILs) in colorectal cancer using hematoxylin and eosin (H-E)-stained tumor sections.
Iseki Y; Shibutani M; Maeda K; Nagahara H; Fukuoka T; Matsutani S; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M
PLoS One; 2018; 13(4):e0192744. PubMed ID: 29698402
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of Hematoxylin and eosin staining tumor-infiltrating lymphocytes (H&E-TILs) in patients with esophageal squamous cell carcinoma treated with chemoradiotherapy.
Zheng J; Zhang H; Li S; Kang Z; Zheng F; Yao Q; Zhang X; Wu Z; Wang J; Fang W; Li J; Chen G; Chen Y; Chen M
BMC Cancer; 2023 Dec; 23(1):1193. PubMed ID: 38053017
[TBL] [Abstract][Full Text] [Related]
4. Tumor-infiltrating Lymphocytes Predict the Chemotherapeutic Outcomes in Patients with Stage IV Colorectal Cancer.
Shibutani M; Maeda K; Nagahara H; Fukuoka T; Iseki Y; Matsutani S; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M
In Vivo; 2018; 32(1):151-158. PubMed ID: 29275313
[TBL] [Abstract][Full Text] [Related]
5. Stromal tumor-infiltrating lymphocytes evaluated on H&E-stained slides are an independent prognostic factor in epithelial ovarian cancer and ovarian serous carcinoma.
Hwang C; Lee SJ; Lee JH; Kim KH; Suh DS; Kwon BS; Choi KU
Oncol Lett; 2019 May; 17(5):4557-4565. PubMed ID: 30944645
[TBL] [Abstract][Full Text] [Related]
6. Overall assessment of tumor-infiltrating lymphocytes in head and neck squamous cell carcinoma: time to take notice.
Almangush A; Leivo I; Mäkitie AA
Acta Otolaryngol; 2020 Mar; 140(3):246-248. PubMed ID: 32022615
[No Abstract] [Full Text] [Related]
7. Tumor-infiltrating lymphocytes in oral cavity squamous cell carcinoma and its association with clinicopathological parameters.
Ahuja S; Khan AA; Zaheer S; Ranga S
Pathol Res Pract; 2023 Nov; 251():154882. PubMed ID: 37898039
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of tumor-infiltrating lymphocytes and neutrophil-to-lymphocyte ratio in patients with stage III colon cancer who underwent surgery followed by FOLFOX chemotherapy.
Cha YJ; Park EJ; Baik SH; Lee KY; Kang J
Sci Rep; 2019 Aug; 9(1):11617. PubMed ID: 31406179
[TBL] [Abstract][Full Text] [Related]
9. Tumor-infiltrating lymphocytes associate with outcome in nonendemic nasopharyngeal carcinoma: a multicenter study.
Almangush A; Ruuskanen M; Hagström J; Hirvikoski P; Tommola S; Kosma VM; Nieminen P; Mäkitie A; Leivo I
Hum Pathol; 2018 Nov; 81():211-219. PubMed ID: 30030117
[TBL] [Abstract][Full Text] [Related]
10. Tumor-infiltrating lymphocytes as easily accessible prognostic tool in adenocarcinoma of the colon.
Zakhartseva L; Shkurupii B
Exp Oncol; 2021 Dec; 43(4):331-335. PubMed ID: 34967541
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of tumour-infiltrating lymphocytes in breast cancer and its prognostic significance.
Althobiti M; Aleskandarany MA; Joseph C; Toss M; Mongan N; Diez-Rodriguez M; Nolan CC; Ashankyty I; Ellis IO; Green AR; Rakha EA
Histopathology; 2018 Dec; 73(6):887-896. PubMed ID: 29947077
[TBL] [Abstract][Full Text] [Related]
12. Standardized approach for evaluating tumor infiltrating lymphocytes in canine mammary carcinoma: Spatial distribution and score as relevant features of tumor malignancy.
Muscatello LV; Avallone G; Brunetti B; Bacci B; Foschini MP; Sarli G
Vet J; 2022; 283-284():105833. PubMed ID: 35489672
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of tumor-infiltrating lymphocytes investigated using routine H&E slides in small cell lung cancer.
Zhou G; Zheng J; Chen Z; Hu D; Li S; Zhuang W; He Z; Lin G; Wu B; Zhang W; Fang W; Zheng F; Wang J; Chen G; Chen M
Radiat Oncol; 2022 Jul; 17(1):127. PubMed ID: 35850908
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Tumor infiltrating lymphocytes in breast carcinoma and their correlation with molecular subtypes, tumor grade and stage.
Pujani M; Jain H; Chauhan V; Agarwal C; Singh K; Singh M
Breast Dis; 2020; 39(2):61-69. PubMed ID: 32310155
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: a retrospective study.
Shibutani M; Maeda K; Nagahara H; Fukuoka T; Matsutani S; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M
BMC Cancer; 2018 Apr; 18(1):371. PubMed ID: 29614981
[TBL] [Abstract][Full Text] [Related]
16. The prognostic significance of tumor-infiltrating lymphocytes assessment with hematoxylin and eosin sections in resected primary lung adenocarcinoma.
Kim A; Lee SJ; Ahn J; Park WY; Shin DH; Lee CH; Kwon H; Jeong YJ; Ahn HY; I H; Kim YD; Cho JS
PLoS One; 2019; 14(11):e0224430. PubMed ID: 31743333
[TBL] [Abstract][Full Text] [Related]
17. Tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the International Immuno-Oncology Biomarker Working Group.
Almangush A; Jouhi L; Atula T; Haglund C; Mäkitie AA; Hagström J; Leivo I
Br J Cancer; 2022 Jun; 126(11):1589-1594. PubMed ID: 35043007
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Tumor-infiltrating Lymphocytes Predicts the Behavior of Early-stage Oral Tongue Cancer.
Heikkinen I; Bello IO; Wahab A; Hagström J; Haglund C; Coletta RD; Nieminen P; Mäkitie AA; Salo T; Leivo I; Almangush A
Am J Surg Pathol; 2019 Oct; 43(10):1392-1396. PubMed ID: 31290758
[TBL] [Abstract][Full Text] [Related]
19. Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study.
Romagnoli G; Wiedermann M; Hübner F; Wenners A; Mathiak M; Röcken C; Maass N; Klapper W; Alkatout I
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885584
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer.
Feng W; Li Y; Shen L; Cai XW; Zhu ZF; Chang JH; Xiang JQ; Zhang YW; Chen HQ; Fu XL
Oncotarget; 2016 Feb; 7(6):7227-40. PubMed ID: 26811495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
